IGM Biosciences, Inc. Proceeds from Common Stock Issued
IGM Biosciences, Inc. reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2025-03-06
- IGM Biosciences, Inc. proceeds from issuance of common stock for the quarter ending 2023-12-31 was $0.00.
- IGM Biosciences, Inc. proceeds from issuance of common stock for the quarter ending 2023-09-30 was $0.00.
- IGM Biosciences, Inc. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00.
- IGM Biosciences, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00.
- IGM Biosciences, Inc. proceeds from issuance of common stock for fiscal 2024 was $0.00.
- IGM Biosciences, Inc. proceeds from issuance of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IGM Biosciences, Inc. proceeds from issuance of common stock for fiscal 2022 was $217.99M.
- IGM Biosciences, Inc. proceeds from issuance of common stock for fiscal 2021 was $0.00.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | |||
| 2023-06-30 | $0.00 10-Q · filed 2023-08-03 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $217.99M 10-K · filed 2025-03-06 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $217.99M 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | $217.99M 10-Q · filed 2023-08-03 | ||||
| 2022-04-01 | $218.00M 10-Q · filed 2022-05-09 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | $11.00K 10-K · filed 2022-03-29 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $11.00K 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $11.00K 10-Q · filed 2020-08-06 |